[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349969-105":59,"doc-detail-349969-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","tumor-characteristics-impact-prognosis-in-deficient-mismatch-repairmicrosatellite-instability-high-localized-colorectal-cancer-meta-analysis","Tumor characteristics impact prognosis in deficient mismatch repair/microsatellite instability-high localized colorectal cancer - meta-analysis","","Deficient mismatch repair (dMMR) and microsatellite instability-high (MSI-H) tumors account for about 15% of localized colorectal cancers. Tumor-infiltrating lymphocytes (TILs) and oncogenic alterations such as BRAF and KRAS mutations may influence survival and guide personalized care. This systematic review and meta-analysis evaluated their impact on overall survival, disease-free survival, and cancer-specific survival using evidence from 2004–2023. High TIL density related to better OS and DFS, while BRAF and KRAS mutations predicted worse OS.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/tumor-characteristics-impact-prognosis-in-deficient-mismatch-repairmicrosatellite-instability-high-localized-colorectal-cancer-meta-analysis/349969/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/tumor-characteristics-impact-prognosis-in-deficient-mismatch-repairmicrosatellite-instability-high-localized-colorectal-cancer-meta-analysis/349969.png","ImageObject",300,407,{"name":92,"@type":93},"Ophelia","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What patient group and biomarkers does the study focus on?","Question",{"text":112,"@type":113},"The study focuses on localized colorectal cancer with deficient mismatch repair (dMMR) and microsatellite instability-high (MSI-H). It evaluates prognostic biomarkers including tumor-infiltrating lymphocytes (TILs) and BRAF and KRAS mutations.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What outcomes were analyzed in the meta-analysis?",{"text":117,"@type":113},"The primary outcomes were overall survival (OS), disease-free survival (DFS), and cancer-specific survival, with bias assessed using the Newcastle-Ottawa Scale and evidence certainty using GRADE.",{"name":119,"@type":110,"acceptedAnswer":120},"How are TIL density and BRAF/KRAS mutations associated with prognosis?",{"text":121,"@type":113},"Higher TIL density was associated with improved OS and DFS. In contrast, BRAF and KRAS mutations were associated with worse OS in patients with localized dMMR/MSI-H colorectal cancer.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},349969,1790378997,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},7971461741311,"https://ap-avatar.wpscdn.com/avatar/74000253aff267980c6?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779345379180704826","JNCI Cancer Spectrum, 2026, 10(2), pkaf114  \n[https://doi.org/10.1093/jncics/pkaf114](https://doi.org/10.1093/jncics/pkaf114)  \nAdvance Access Publication Date: December 4, 2025  \nMeta-Analysis  \nTumor characteristics impact prognosis in deficient mismatch repair/microsatellite instability-high localized colorectal cancer—a systematic review and  \nmeta-analysis  \nIda Kolukisa Saqi, MD1, Amalie Thomsen Nielsen , BSc1, Michael Tvilling Madsen , MD, PhD2, Ismail G€ogenur , MD, DMSc1,3, Adile Orhan , MD1, Tobias Freyberg Justesen , MD􀀃 ,1  \n1Center for Surgical Science, Department of Surgery, Zealand University Hospital, Køge, Denmark 2Department of Surgery, Slagelse Hospital, Slagelse, Denmark  \n3Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark  \n􀀃 Corresponding author: Tobias Freyberg Justesen, MD, Center for Surgical Science, Department of Surgery, Zealand University Hospital, Køge, Lykkebækvej 1, 4600 Køge, Denmark ([toju@regionsjaelland.dk](toju@regionsjaelland.dk)) .  \nAuthor Contributions: I.K. Saqi and A.T. Nielsen shared first authorship.  \nAuthor Contributions: A. Orhan and T.F. Justesen shared last authorship.  \nAbstract  \nBackground: Deficient mismatch repair (dMMR) and microsatellite instability-high (MSI-H) tumors constitute 􀀘 15% of localized colorectal cancers (CRCs). Prognostic biomarkers such as tumor-infiltrating lymphocytes (TILs) and BRAF and KRAS mutations may guide personalized treatment for these patients, and this systematic review and meta-analysis aimed to evaluate their impact on survival outcomes. Methods: Literature searches were conducted across PubMed, Embase, Cochrane Library, and Web of Science, including studies published between 2004 and 2023. The primary outcomes were overall survival (OS), disease-free survival (DFS), and cancer-specific survival. The risk of bias was assessed using the Newcastle-Ottawa Scale, and the certainty of evidence using the GRADE approach. Results: The literature search yielded 5636 articles. Fifty-four studies were included in the systematic review and 31 studies in the meta-analysis, totaling 4551 patients. High TIL density was significantly associated with improved OS (hazard ratio [HR] ¼ 0.39, 95% CI ¼ 0.17 to 0.89) and DFS (HR ¼ 0.45, 95% CI ¼ 0.29 to 0.71) . BRAF and KRAS mutations were seen in 52% and 34% of patients, respectively, and were associated with poorer OS (HR ¼ 1.43, 95% CI ¼ 1.13 to 1.80 and HR ¼ 1.30, 95% CI ¼ 1.09 to 1.54, respectively) . Quality of evidence was moderate to high across all exposures and outcomes.  \nConclusion: High infiltration of TILs correlated with improved OS and DFS, whereas BRAF and KRAS mutations were associated with worse OS in patients with localized dMMR/MSI-H CRC. These findings highlight the potential utility of biomarkers for improving prognostic assessment and personalizing management in dMMR CRC.  \nIntroduction  \nColorectal cancer (CRC) is the third most common cancer worldwide with nearly 2 million new patient cases reported in 2022,1 and the number is projected to rise to 3.2 million by 2040.2 With the rising incidence of CRC and increased focus on immunotherapy, it is important to further understand the underlying factors influencing the prognosis in patients with CRC. Deficient mismatch repair (dMMR) and microsatellite instability-high (MSI-H) status are present in 􀀘 10%-15% of patients diagnosed with localized CRC.3 ,4 The dMMR pathway results from the inactivation of DNA mismatch repair genes, which normally maintain genomic stability by correcting DNA mismatch mutations.5 , 6 Sporadic dMMR tumors are most often caused by MLH1 promoter hypermethylation, resulting in epigenetic silencing of the gene. In contrast, hereditary dMMR cases arise predominantly from germline  \nMLH1 or MSH2 mutations, which represent the main cause of Lynch syndrome, accounting for 􀀘 15%-20% of all dMMR CRCs.7-9 Compared with proficient mismatch repair (pMMR) or microsatellite stable tumors, localized dMMR","cbCailQHVfQQtIBc","https://ap.wps.com/l/cbCailQHVfQQtIBc","pdf",1854153,13,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What patient group and biomarkers does the study focus on?\",\"answer\":\"The study focuses on localized colorectal cancer with deficient mismatch repair (dMMR) and microsatellite instability-high (MSI-H). It evaluates prognostic biomarkers including tumor-infiltrating lymphocytes (TILs) and BRAF and KRAS mutations.\"},{\"question\":\"What outcomes were analyzed in the meta-analysis?\",\"answer\":\"The primary outcomes were overall survival (OS), disease-free survival (DFS), and cancer-specific survival, with bias assessed using the Newcastle-Ottawa Scale and evidence certainty using GRADE.\"},{\"question\":\"How are TIL density and BRAF/KRAS mutations associated with prognosis?\",\"answer\":\"Higher TIL density was associated with improved OS and DFS. In contrast, BRAF and KRAS mutations were associated with worse OS in patients with localized dMMR/MSI-H colorectal cancer.\"}]","Tumor characteristics impact prognosis in deficient mismatch repair/microsatellite instability-high localized colorectal cancer - meta-analysis | PDF",1790086519,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/28f90b7979fc9c1bf3cc0036471611a5.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4276813cf34e50266aae6383384af90e.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4e609d78ad9dfda913d045776e217507.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4ccbc5444d4d2bc9e448385ebd082617.webp",980,1287]